You are here: Industry Insights > Sartorius

News List

Sartorius extends its cell culture media business via acquisition cphi-online
August 03, 2021
Acquiring Xell AG will enable Sartorius to offer specialised media for manufacturing viral vectors
Sartorius Strengthens Cell and Gene Therapy Portfolio With Majority Stake of CellGenix americanpharmaceuticalreview
July 05, 2021
Sartorius acquired a majority stake in the reagent manufacturer CellGenix, a German producer and marketer of cell culture components including - growth factors, cytokines and media in GMP quality for manufacturing cell and gene therapy products.
Sartorius Expands Production Capacities for the Purification of Vaccines and Therapeutics americanpharmaceuticalreview
June 02, 2021
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, will open its expanded production facilities in Ajdovscina, Slovenia. The area for manufacturing and labs will increase from 3,000 square meters to ...
Sartorius Expands in the UK contractpharma
April 19, 2021
Sartorius will open a new state-of-the-art manufacturing facility in Havant, Hampshire, UK. More than 90 employees will relocate to the new facility near the former site in Portsmouth.
Sartorius to Acquire Novasep's Chromatography Biz contractpharma
January 07, 2021
Novasep's division expects to generate sales of approximately €37 million in 2020 with double-digit profit margins.
Evotec and Sartorius Partner with Curexsys contractpharma
December 10, 2020
Evotec SE and the life science company Sartorius have entered into a partnership with the recently established Curexsys GmbH, a Goettingen, Germany-based technology company specializing in the emerging field of therapeutic exosomes.
Sartorius Joins DFKI to Support AI for Advanced Medicines contractpharma
September 27, 2020
Conducting research on deep learning algorithms for modeling of biological systems and for optimization of biopharmaceutical production processes.
Sartorius Launches Incucyte SX5 for Live-Cell Analysis contractpharma
May 12, 2020
Sartorius has launched the new Incucyte SX5 Live-Cell Analysis System with new capabilities, including novel optics, a new line of paired reagents, and purpose-built software to help enable researchers to gain greater insight from live cell experiments.
Sartorius Closes Acquisition of Danaher Life Sciences Selected Assets americanpharmaceuticalreview
May 07, 2020
Sartorius has closed the acquisition of selected life science businesses of Danaher Corporation. The transaction was completed on April 30, 2020, after receiving the required regulatory approvals.
Sartorius Completes $825M Acquisition of Danaher Businesses contractpharma
May 04, 2020
Expands market position in bioanalytics and key areas of the manufacture of biopharmaceuticals.

Previous page 1 2 3 4 5 Next page